U.S. Markets closed

5 Value Stocks to Benefit From Positive Vaccine News

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·5 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Encouraging developments on the COVID-19 vaccine front bodes well for economic growth, and in turn should boost value stocks mostly perceived to be cyclical in nature. These economically-sensitive stocks that have been so far battered by the pandemic can now finally turn around. When the pandemic forced the United States to go into a lockdown, these stocks, which are largely depended on the proper functioning of the economy, took a hit. Businesses and stores were shut and people had to stay at home to avoid the risk of exposure. This led the economy into a downfall wherein all indicators pointed toward a recession.

However, over the past few months, the economy has seen a turnaround. Indicators began to improve with the third-quarter GDP rising substantially. Per the “advance” estimate released by the Bureau of Economic Analysis, real GDP expanded at an annual rate of 33.1% following the dip of 31.4% in the second quarter. Moreover, the Commerce Department reported that new orders for manufactured goods held up for five consecutive months through September. It rose 1.1% in September following a 0.6% increase in August, as quoted in a Reuters article. Meanwhile, manufacturing activity continued to witness expansion. The manufacturing purchasing manager’s index expanded for the sixth month in a row in October at 59.3%, per the latest release by the Institute of Supply Management.

These positive indicators have been a result of economic activities slowly resuming with both demand and supply returning. So, the promising news with regard to vaccine for COVID-19 will only add strength to this recovery. It will also, in turn, allow value stocks to rebound as demand will increase as a result of consumers being encouraged to spend more.

Coming to vaccine news, on Nov 16, Moderna, Inc. MRNA announced in a press release that their vaccine candidate was found to be 94.5% effective in the first interim analysis of Phase 3. This positive news comes on the heels of Pfizer Inc. PFE and BioNTech SE’s BNTX announcement of their vaccine’s effectiveness last week. Per a press release issued by the companies on Nov 9, their vaccine candidate was found to be more than 90% effective.

Moreover, Moderna announced in another press release that its vaccine remained stable at “2° to 8°C (36° to 46°F), the temperature of a standard home or medical refrigerator, for 30 days.” It will also remain stable at “-20° C (-4°F) for up to six months.” Such news is promising for the economy as a vaccine will be effective in starting the complete recovery from the pandemic that it needs.

5 Top Value Stock to Buy Now

Positive news related to the vaccine will allow the economy to open up. These will lead to the resumption of activities, which have been hindered by the stay-at-home requirements. Hence, it will be prudent to invest in value stocks which stand to benefit from this development. Thanks to our style score system, we have been able to identify five value stocks. Our research shows that stocks with a Value Score of A or B when combined with a Zacks Rank #1 (Strong Buy) or 2 (Buy) offer the best opportunities in the value investing space. You can see the complete list of today’s Zacks #1 Rank stocks here.

Brinker International, Inc. EAT, through its subsidiaries, owns, develops, operates and franchises casual dining restaurants in the United States. The company currently has a Zacks Rank #1. It also currently has a Value Score B. The Zacks Consensus Estimate for its current-year earnings has moved 33.3% north over the past 60 days. The company’s expected earnings growth rate for the current year is 61.4%.

Vista Outdoor Inc. VSTO operates through shooting sports and outdoor products segments, and designs, manufactures and markets consumer products for outdoor sports and recreation markets in the United States. The company currently has a Zacks Rank #1. It also currently has a Value Score A. The Zacks Consensus Estimate for its current-year earnings has risen 36.4% over the past 60 days. The company’s expected earnings growth rate for the current year is more than 100%.

Brunswick Corporation BC designs, manufactures and markets recreation products in the United States. The company currently has a Zacks Rank #2. It also currently has a Value Score B. The Zacks Consensus Estimate for its current-year earnings has climbed 15.1% over the past 60 days. The company’s expected earnings growth rate for the current year is 9%.

Fiesta Restaurant Group, Inc. FRGI, through its subsidiaries, owns, operates and franchises fast-casual restaurants in the United States. The company currently has a Zacks Rank #2. It also currently has a Value Score A. The Zacks Consensus Estimate for its next-year earnings has moved up 85.7% over the past 60 days. The company’s expected earnings growth rate for the next quarter is over 100%.

Malibu Boats, Inc. MBUU designs, manufactures, markets and sells recreational products in the United States. The company currently has a Zacks Rank #2. It also currently has a Value Score B. The Zacks Consensus Estimate for its current-year earnings has risen 10.3% over the past 60 days. The company’s expected earnings growth rate for the current year is 46.8%.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.  

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pfizer Inc. (PFE) : Free Stock Analysis Report
 
Brinker International, Inc. (EAT) : Free Stock Analysis Report
 
Moderna, Inc. (MRNA) : Free Stock Analysis Report
 
Brunswick Corporation (BC) : Free Stock Analysis Report
 
Fiesta Restaurant Group, Inc. (FRGI) : Free Stock Analysis Report
 
Malibu Boats, Inc. (MBUU) : Free Stock Analysis Report
 
Vista Outdoor Inc. (VSTO) : Free Stock Analysis Report
 
BioNTech SE Sponsored ADR (BNTX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research